The diagnosis and management of multiple-drug-resistant-tuberculosis at the beginning of the new millenium (Q34666642)

3 August 2017

1 reference

title

The diagnosis and management of multiple-drug-resistant-tuberculosis at the beginning of the new millenium (English)

1 reference

multidrug-resistant tuberculosis

3 August 2017

multiple drug resistance

1 reference

1 reference

0 references

author name string

F A Drobniewski

series ordinal

1

1 reference

PubMed ID

12044286

3 August 2017

Yanina M Balabanova

series ordinal

2

1 reference

3 August 2017

1 March 2002

1 reference

International Journal of Infectious Diseases

3 August 2017

1 reference

3 August 2017

6 Suppl 1

1 reference

3 August 2017

S21-31

1 reference

Global epidemiology of tuberculosis. Morbidity and mortality of a worldwide epidemic

3 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS1201-9712%2802%2990151-7

7 January 2021

Epidemiology of Tuberculosis in the World

1 reference

https://api.crossref.org/works/10.1016%2FS1201-9712%2802%2990151-7

7 January 2021

Consensus statement. Global burden of tuberculosis: estimated incidence, prevalence, and mortality by country. WHO Global Surveillance and Monitoring Project

1 reference

https://api.crossref.org/works/10.1016%2FS1201-9712%2802%2990151-7

7 January 2021

Tuberculosis at the end of the 20th century in England and Wales: results of a national survey in 1998.

1 reference

https://api.crossref.org/works/10.1016%2FS1201-9712%2802%2990151-7

7 January 2021

Multiple drug resistant tuberculosis: aetiology, diagnosis and outcome

1 reference

https://api.crossref.org/works/10.1016%2FS1201-9712%2802%2990151-7

7 January 2021

Global surveillance for antituberculosis-drug resistance, 1994-1997. World Health Organization-International Union against Tuberculosis and Lung Disease Working Group on Anti-Tuberculosis Drug Resistance Surveillance.

1 reference

https://api.crossref.org/works/10.1016%2FS1201-9712%2802%2990151-7

7 January 2021

Drug-resistant tuberculosis: review of the worldwide situation and the WHO/IUATLD Global Surveillance Project. International Union Against Tuberculosis and Lung Disease

1 reference

https://api.crossref.org/works/10.1016%2FS1201-9712%2802%2990151-7

7 January 2021

Database study of antibiotic resistant tuberculosis in the United Kingdom, 1994-6.

1 reference

https://api.crossref.org/works/10.1016%2FS1201-9712%2802%2990151-7

7 January 2021

Tuberculosis in Siberia: 1. An epidemiological and microbiological assessment

1 reference

https://api.crossref.org/works/10.1016%2FS1201-9712%2802%2990151-7

7 January 2021

Specific features of the spread of tuberculosis in Russia at the end of the 20th century.

1 reference

https://api.crossref.org/works/10.1016%2FS1201-9712%2802%2990151-7

7 January 2021

The resurgence of tuberculosis in Russia

1 reference

https://api.crossref.org/works/10.1016%2FS1201-9712%2802%2990151-7

7 January 2021

Tuberculosis in Siberia: 2. Diagnosis, chemoprophylaxis and treatment

1 reference

https://api.crossref.org/works/10.1016%2FS1201-9712%2802%2990151-7

7 January 2021

Tuberculosis in prisons--forgotten plague

1 reference

https://api.crossref.org/works/10.1016%2FS1201-9712%2802%2990151-7

7 January 2021

Rapid assessment of drug susceptibilities of Mycobacterium tuberculosis by means of luciferase reporter phages

1 reference

https://api.crossref.org/works/10.1016%2FS1201-9712%2802%2990151-7

7 January 2021

Rapid film-based determination of antibiotic susceptibilities of Mycobacterium tuberculosis strains by using a luciferase reporter phage and the Bronx Box.

1 reference

https://api.crossref.org/works/10.1016%2FS1201-9712%2802%2990151-7

7 January 2021

Evaluation of a new rapid bacteriophage-based method for the drug susceptibility testing of Mycobacterium tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FS1201-9712%2802%2990151-7

7 January 2021

Evaluation of reverse transcription-PCR and a bacteriophage-based assay for rapid phenotypic detection of rifampin resistance in clinical isolates of Mycobacterium tuberculosis.

1 reference

https://api.crossref.org/works/10.1016%2FS1201-9712%2802%2990151-7

7 January 2021

Evaluation of a bacteriophage-based assay (phage amplified biologically assay) as a rapid screen for resistance to isoniazid, ethambutol, streptomycin, pyrazinamide, and ciprofloxacin among clinical isolates of Mycobacterium tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FS1201-9712%2802%2990151-7

7 January 2021

Simultaneous genotyping and species identification using hybridization pattern recognition analysis of generic Mycobacterium DNA arrays

1 reference

https://api.crossref.org/works/10.1016%2FS1201-9712%2802%2990151-7

7 January 2021

A clinical, microbiological and economic analysis of a national service for the rapid molecular diagnosis of tuberculosis and rifampicin resistance in Mycobacterium tuberculosis.

1 reference

https://api.crossref.org/works/10.1016%2FS1201-9712%2802%2990151-7

7 January 2021

Measurement of sputum Mycobacterium tuberculosis messenger RNA as a surrogate for response to chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS1201-9712%2802%2990151-7

7 January 2021

Molecular diagnosis of tuberculosis: current clinical validity and future perspectives

1 reference

https://api.crossref.org/works/10.1016%2FS1201-9712%2802%2990151-7

7 January 2021

Is death inevitable with multiresistant TB plus HIV infection?

1 reference

https://api.crossref.org/works/10.1016%2FS1201-9712%2802%2990151-7

7 January 2021

Nonadherence in tuberculosis treatment: predictors and consequences in New York City.

1 reference

https://api.crossref.org/works/10.1016%2FS1201-9712%2802%2990151-7

7 January 2021

The relationship between delayed or incomplete treatment and all-cause mortality in patients with tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FS1201-9712%2802%2990151-7

7 January 2021

Low antituberculosis drug concentrations in patients with AIDS.

1 reference

https://api.crossref.org/works/10.1016%2FS1201-9712%2802%2990151-7

7 January 2021

Resource implications of patients with multidrug resistant tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FS1201-9712%2802%2990151-7

7 January 2021

Multiple-drug-resistant tuberculosis.

1 reference

https://api.crossref.org/works/10.1016%2FS1201-9712%2802%2990151-7

7 January 2021

Treatment of multidrug-resistant tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FS1201-9712%2802%2990151-7

7 January 2021

Chemotherapy and management of tuberculosis in the United Kingdom: recommendations 1998

1 reference

https://api.crossref.org/works/10.1016%2FS1201-9712%2802%2990151-7

7 January 2021

First-line tuberculosis therapy and drug-resistant Mycobacterium tuberculosis in prisons

1 reference

https://api.crossref.org/works/10.1016%2FS1201-9712%2802%2990151-7

7 January 2021

Treatment of 171 patients with pulmonary tuberculosis resistant to isoniazid and rifampin

1 reference

https://api.crossref.org/works/10.1016%2FS1201-9712%2802%2990151-7

7 January 2021

Multidrug-resistant tuberculosis in patients without HIV infection

1 reference

https://api.crossref.org/works/10.1016%2FS1201-9712%2802%2990151-7

7 January 2021

Predictors and outcome of multidrug-resistant tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FS1201-9712%2802%2990151-7

7 January 2021

Improved outcomes for patients with multidrug-resistant tuberculosis.

1 reference

https://api.crossref.org/works/10.1016%2FS1201-9712%2802%2990151-7

7 January 2021

Outcome of MDR-TB patients, 1983-1993. Prolonged survival with appropriate therapy.

1 reference

https://api.crossref.org/works/10.1016%2FS1201-9712%2802%2990151-7

7 January 2021

The treatment of multidrug-resistant tuberculosis in Turkey

1 reference

https://api.crossref.org/works/10.1016%2FS1201-9712%2802%2990151-7

7 January 2021

A national study of clinical and laboratory factors affecting the survival of patients with multiple drug resistant tuberculosis in the UK

1 reference

https://api.crossref.org/works/10.1016%2FS1201-9712%2802%2990151-7

7 January 2021

Standard short-course chemotherapy for drug-resistant tuberculosis: treatment outcomes in 6 countries

1 reference

https://api.crossref.org/works/10.1016%2FS1201-9712%2802%2990151-7

7 January 2021

Diagnosing multidrug resistant tuberculosis in Britain. Clinical suspicion should drive rapid diagnosis

1 reference

https://api.crossref.org/works/10.1016%2FS1201-9712%2802%2990151-7

7 January 2021

Antituberculosis activity of once-weekly rifapentine-containing regimens in mice. Long-term effectiveness with 6- and 8-month treatment regimens

1 reference

https://api.crossref.org/works/10.1016%2FS1201-9712%2802%2990151-7

7 January 2021

Acquired rifamycin monoresistance in patients with HIV-related tuberculosis treated with once-weekly rifapentine and isoniazid. Tuberculosis Trials Consortium

1 reference

https://api.crossref.org/works/10.1016%2FS1201-9712%2802%2990151-7

7 January 2021

Safety and bactericidal activity of rifalazil in patients with pulmonary tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FS1201-9712%2802%2990151-7

7 January 2021

Sustained release of isoniazid in vivo from a single implant of a biodegradable polymer

1 reference

https://api.crossref.org/works/10.1016%2FS1201-9712%2802%2990151-7

7 January 2021

Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence

1 reference

https://api.crossref.org/works/10.1016%2FS1201-9712%2802%2990151-7

7 January 2021

Immunotherapy with Mycobacterium vaccae in the treatment of tuberculosis in Romania. 1. Newly-diagnosed pulmonary disease

1 reference

https://api.crossref.org/works/10.1016%2FS1201-9712%2802%2990151-7

7 January 2021

An essential role for interferon gamma in resistance to Mycobacterium tuberculosis infection

1 reference

https://api.crossref.org/works/10.1016%2FS1201-9712%2802%2990151-7

7 January 2021

Treatment of refractory disseminated nontuberculous mycobacterial infection with interferon gamma. A preliminary report

1 reference

https://api.crossref.org/works/10.1016%2FS1201-9712%2802%2990151-7

7 January 2021

A mutation in the interferon-gamma-receptor gene and susceptibility to mycobacterial infection

1 reference

https://api.crossref.org/works/10.1016%2FS1201-9712%2802%2990151-7

7 January 2021

Treatment of multidrug-resistant pulmonary tuberculosis with interferon-gamma via aerosol

1 reference

https://api.crossref.org/works/10.1016%2FS1201-9712%2802%2990151-7

7 January 2021

Role of surgery in multi-drug-resistant tuberculosis: results of 27 cases

1 reference

https://api.crossref.org/works/10.1016%2FS1201-9712%2802%2990151-7

7 January 2021

Surgical intervention in the treatment of pulmonary disease caused by drug-resistant Mycobacterium tuberculosis.

1 reference

https://api.crossref.org/works/10.1016%2FS1201-9712%2802%2990151-7

7 January 2021

10.1016/S1201-9712(02)90151-7

Identifiers

DOI

1 reference

3 August 2017

1 reference

PubMed ID

12044286